Target intelligence / Profile preview

Dystrophin protein (Dystrophin)

Target
Dystrophin
Molecular classification
Cytoskeletal protein, Adapter/scaffold protein
01

Overview

Dystrophin is a large cytoskeletal protein encoded by the *DMD* gene on the X chromosome. It functions as an essential mechanical stabilizer in skeletal and cardiac muscle cells, connecting the internal actin cytoskeleton of muscle fibers to the extracellular matrix via the dystrophin-associated protein complex (DAPC). Dystrophin plays a critical role in protecting muscle cells from contraction-induced injury by anchoring actin filaments to the plasma membrane and ensuring sarcolemma stability. Loss-of-function mutations in dystrophin cause Duchenne and Becker muscular dystrophies, leading to progressive muscle degeneration and weakness[1][4][7]. AAVrh74-mediated micro-dystrophin gene transfer is a therapeutic strategy for Duchenne muscular dystrophy (DMD), using an adeno-associated virus vector (AAVrh74) to deliver a shortened functional dystrophin (micro-dystrophin) gene to muscle tissue. This therapy aims to restore dystrophin function in skeletal and cardiac muscle, improve muscle stability, and slow disease progression. Micro-dystrophin is engineered to retain key functional domains necessary for membrane stabilization and protein complex formation while being small enough for efficient AAV packaging and delivery[2][5][8].

Other names
DMD proteinDystrophin-associated proteinRod domain protein
02

Mechanism of action

Gene transfer (AAV-mediated), Restoration of dystrophin function in muscle, Cell membrane stabilization

03

Biological functions

Cytoskeletal stabilizationMechanical supportMuscle cell integritySarcolemma stabilizationSignal transductionScaffold for protein complexes
04

Disease associations

Neuromuscular diseaseMuscular dystrophyCardiomyopathy
05

Safety considerations

Immune response to AAV vectorPre-existing anti-AAVrh74 antibodiesOff-target transductionVector sheddingLiver toxicityDose-related adverse events
06

Interacting drugs

Delandistrogene moxeparvovec (SRP-9001)

1 more in the full profile.

07

Biomarkers

Dystrophin protein expression (muscle biopsy immunostaining)Dystrophin mRNA levelsCreatine kinase (CK)

Beyond the preview

Go deeper on Dystrophin protein (Dystrophin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophin protein (Dystrophin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call